ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,367
Screening encounters
3,897
Diagnostic referrals
744
Outstanding pathways
280

Screening pathway

  1. Screening3,897Encounters
  2. Positive finding1,352Documented findings
  3. Referral744Diagnostic referrals
  4. Follow-up872Diagnostic visits
  5. Outcome464Resolved pathways

Stage totals use different units. Pending pathways: 280. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3154 · EXP-3154Synthetic · Site C

Full participant history through 2026-08-24, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-30
  4. · Diagnostic referral · EXP-3154-T-R
  5. · Barrier documented · Contact difficulty
  6. · Contact attempt · Reached
  7. · Diagnostic booking · Initial booking
  8. · Barrier documented · Transport difficulty
  9. · Navigation intervention · Coordination support
  10. · Diagnostic visit · Missed
  11. · Diagnostic booking · Rebooking
  12. · Diagnostic visit · Missed
  13. · Screening · HPV DNA · Repeat · Prior VIA positive
  14. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3367 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3043 · Expanded synthetic participant 3043Site D — Community Engagement Programme
EXP-3044 · Expanded synthetic participant 3044Site D — Community Engagement Programme
EXP-3045 · Expanded synthetic participant 3045Site D — Community Engagement Programme
EXP-3046 · Expanded synthetic participant 3046Site E — Resource-Constrained Navigation Programme
EXP-3047 · Expanded synthetic participant 3047Site B — Peri-Urban Access Programme
EXP-3049 · Expanded synthetic participant 3049Site D — Community Engagement Programme
EXP-3052 · Expanded synthetic participant 3052Site E — Resource-Constrained Navigation Programme
EXP-3053 · Expanded synthetic participant 3053Site D — Community Engagement Programme
EXP-3054 · Expanded synthetic participant 3054Site C — Rural Outreach Programme
EXP-3055 · Expanded synthetic participant 3055Site C — Rural Outreach Programme
EXP-3056 · Expanded synthetic participant 3056Site D — Community Engagement Programme
EXP-3057 · Expanded synthetic participant 3057Site D — Community Engagement Programme
EXP-3058 · Expanded synthetic participant 3058Site A — Urban Referral Hub
EXP-3059 · Expanded synthetic participant 3059Site C — Rural Outreach Programme
EXP-3060 · Expanded synthetic participant 3060Site A — Urban Referral Hub
EXP-3062 · Expanded synthetic participant 3062Site E — Resource-Constrained Navigation Programme
EXP-3063 · Expanded synthetic participant 3063Site E — Resource-Constrained Navigation Programme
EXP-3066 · Expanded synthetic participant 3066Site E — Resource-Constrained Navigation Programme
EXP-3068 · Expanded synthetic participant 3068Site E — Resource-Constrained Navigation Programme
EXP-3070 · Expanded synthetic participant 3070Site C — Rural Outreach Programme
EXP-3071 · Expanded synthetic participant 3071Site D — Community Engagement Programme
EXP-3073 · Expanded synthetic participant 3073Site B — Peri-Urban Access Programme
EXP-3074 · Expanded synthetic participant 3074Site D — Community Engagement Programme
EXP-3076 · Expanded synthetic participant 3076Site A — Urban Referral Hub
EXP-3079 · Expanded synthetic participant 3079Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1540
HPV DNA
1801
Cytology
556

Navigation activity

Barrier documented
641
Contact attempt
1089
Navigation intervention
274
Diagnostic booking
916
Diagnostic visit
872

Documented barriers

Contact difficulty
213
Transport difficulty
201
Appointment coordination
227

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.